
FDA Endorses Donanemab, Revolutionary Alzheimer’s Treatment
The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer’s. Learn how Leqembi is treating Alzheimer’s around the world.

In a span of 40 years, why did average brain size increase and dementia rates drop? A new UC-Davis study explores environmental factors behind this silent revolution.

“People with dementia living in nursing homes and in the community were prescribed less and we did not detect negative health impacts for these groups.”

LEQEMBI® is the newest Alzheimer’s drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an “Autoinjector”. See how it works and learn its advantages.

The newest and most promising drug to fight Alzheimer’s is Leqembi. Carolyn Davis is giving it a try. Learn about the promise, the risks and how it has restored her hope,

Scheduled to begin on May 9, 2024, six new monthly sessions are now available in this free Continuing Education Program.

People with dementia may be even more vulnerable to fraud and scams than previously thought, according to an NIA study. See the story of one victim with a happy ending. Read the research.

Galantamine treats Alzheimer’s. Artificial intelligence and biosensors may pave the way to make this drug faster and cheaper.

A long, long time ago (1930), brains were smaller. Are today’s bigger brains connected to improvements in rates of dementia?

A beautiful song on living with Alzheimer’s. (Includes lyrics.) Enjoy.

Kindness can become its own motive.We are made kind by being kind. (Eric Hoffer)

Exploring evidence on rosemary and lavender scents and cognitive performance.

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.


